Seeing Is Believing

Currently out of the existing stock ratings of Tim Anderson, 37 are a BUY (38.54%), 45 are a HOLD (46.88%), 14 are a SELL (14.58%).
Analyst Tim Anderson, currently employed at BAML, carries an average stock price target met ratio of 89.69% that have a potential upside of 35.22% achieved within 212 days.
Tim Anderson’s has documented 188 price targets and ratings displayed on 17 stocks. The coverage is on Industrials, Healthcare sectors.
Most recent stock forecast was given on AMGN, Amgen at 05-Aug-2026.
Analyst best performing recommendations are on MLYS (MINERALYS THERAPEUTICS, COMMON STOCK).
The best stock recommendation documented was for MLYS (MINERALYS THERAPEUTICS, COMMON STOCK) at 8/28/2025. The price target of $43 was fulfilled within 46 days with a profit of $27.78 (182.52%) receiving and performance score of 39.68.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 17-Jun-2022
$42
$-1.75 (-4.00%)
$50
Sell Since 02-Apr-2026
$29
$-14.75 (-33.71%)
$27
Buy Since 27-Mar-2026
$41
$-2.75 (-6.29%)
$53
Buy Since 05-Dec-2025
$35
$-8.75 (-20.00%)
$55
Hold Since 28-Jun-2021
$48
$4.25 (9.71%)
$38
Which stock is Tim Anderson is most bullish on?
Which stock is Tim Anderson is most reserved on?
What Year was the first public recommendation made by Tim Anderson?